Corrigendum to “The Annual Assembly of Hospice and Palliative Care Posters March 4 – 7, 2026. Palliative Care Service Delivery Measures and End-of-Life Outcomes for Patients With Advanced Cancers” [Journal of Pain and Symptom Management, 71 (2026) e1139-e1140]

John J. Shin

doi:10.1016/j.jpainsymman.2026.06.014

Impact of Spirulina-enriched yogurt-like dessert on blood pressure in overweight individuals with high cardiometabolic risk: Results from in vitro studies and a randomized, placebo-controlled clinical trial

2026-06-10

0

PRE

AI

E

Emilia Papakonstantinou *

F

Foteini Lympaki

A

Aggeliki Savvidou

E

Eleni Dalaka

G

Georgios Georgiopoulos

M

Marianna Giannoglou

K

Kalliopi Karatzi

S

Stavroula Chaloulakou

D

Dimitrios Delialis

K

Kalliopi Keramida

A

Antonis Zampelas

G

George Katsaros

G

Georgios Theodorou *

DOI：10.1016/j.numecd.2026.104824

Original

Original request for help

Save

Abstract

En 中文

Spirulina (Arthrospira platensis) contains peptides with angiotensin-I converting enzyme (ACE) inhibitory activity, suggesting possible antihypertensive effects. However, food-matrix interactions may alter peptide release or bioactivity. This study evaluated (i) the in-vitro ACE-inhibitory activity of <3kDa peptide fractions after simulated gastrointestinal digestion of spirulina biomass (SB) and a spirulina-enriched yogurt-like dessert (YSB), and (ii) the effects of daily YSB consumption on blood pressure (BP) and vascular function in overweight/obese adults with elevated cardiometabolic risk.

Impact of Spirulina-enriched yogurt-like dessert on blood pressure in overweight individuals with high cardiometabolic risk: Results from in vitro studies and a randomized, placebo-controlled clinical trial

Abstract

Journal

Organization

Cited Papers

Citing Papers